Cefminox: correlation between in-vitro susceptibility and pharmacokinetics and serum bactericidal activity in healthy volunteers

J Antimicrob Chemother. 1994 Jan;33(1):91-101. doi: 10.1093/jac/33.1.91.

Abstract

Plasma concentration of cefminox and serum bactericidal activity against four ATCC strains (Escherichia coli 25992, Klebsiella pneumoniae 13833, Serratia marcescens 8100 and Bacteroides fragilis 25285), were determined over a 24 h period after administration of cefminox 1 and 2 g to six healthy volunteers in a randomized, cross-over, single blind study. The increase observed in the area under the bactericidal curve (AUBC) with the 2 g dose was at least 3.5 times that seen with the 1 g dose for all four test strains and was larger than predicted by the corresponding increase (1.84 times) in the area under the serum concentration versus time curve (AUC); a correlation (r = 0.88, P = 0.0001) between the cefminox concentration and the serum bactericidal titres was, however, observed with all four strains tested. The MBC6h showed a better association with the serum bactericidal titre (P < 0.01) than did the MIC or MBC.

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Bacteria / drug effects*
  • Biological Assay
  • Cephamycins / blood
  • Cephamycins / pharmacokinetics
  • Cephamycins / pharmacology*
  • Chromatography, High Pressure Liquid
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Serum Bactericidal Test
  • Single-Blind Method

Substances

  • Cephamycins
  • cefminox